Ferring Endometrin Vaginal Inserts Recall: Microbial Contamination Risk
Ferring Pharmaceuticals recalls Endometrin 100mg vaginal inserts due to potential microbial contamination in non-sterile products. Affected units include cartons with NDC 55566-6500-03, manufactured until Dec 2025.
Lower-risk recall
cGMP deviations: potential for Microbial Contamination of Non-Sterile Products
Contact the company
What happened, in plain English
Ferring Pharmaceuticals is recalling Endometrin 100mg vaginal inserts that may have microbial contamination. This could pose a health risk if the product is used without proper sterility. Read more at govinfonow.com/recall/33412-ferring-endometrin-vaginal-inserts-recall-microbial-contamination-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/33412-ferring-endometrin-vaginal-inserts-recall-microbial-contamination-risk · Updated September 23, 2026 · FDA enforcement record: FDA #D-0879-2023
Cite this page
“Ferring Endometrin Vaginal Inserts Recall: Microbial Contamination Risk.” GovInfoNow, updated September 23, 2026. https://govinfonow.com/recall/33412-ferring-endometrin-vaginal-inserts-recall-microbial-contamination-risk. Based on FDA recall #D-0879-2023 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0879-2023%22&limit=1).
Why it’s dangerous
The recall is for potential microbial contamination in non-sterile products. This could happen during manufacturing due to cGMP (current Good Manufacturing Practice) deviations. Microbial contamination might lead to infections if the product is used without proper sterility.
Who’s affected
Women using Endometrin vaginal inserts manufactured by Ferring Pharmaceuticals. Those with medical conditions requiring hormone therapy may be at higher risk.
How to tell if you have this one
Check for cartons labeled 'Endometrin (progesterone) Vaginal Insert 100mg' with NDC 55566-6500-03. Products were manufactured until December 2025.
- Brand
Ferring- Category
Drug
What to do — step by step
Check Product Details
Look for the NDC code 55566-6500-03 on the carton label.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “USA Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 14 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Questions people ask
Is this product safe to use?
The recall indicates potential microbial contamination, so it is not recommended for use until the product is replaced.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0879-2023 (June 12, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0879-2023 to see it in context.
- Plain-language summary written by qwen3:4b on September 23, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.